Globe Newswire » trang 158 » Trang Công Nghệ | Trangcongnghe.vn

JASCAYD® (nerandomilast) approved in Japan, advancing global access to a new IPF and PPF treatment

JASCAYD® (nerandomilast) approved in Japan, advancing global access to a new IPF and PPF treatment

Globenewswire -

CAPHRA warns WHO against one-size-fits-all nicotine pouch restrictions

CAPHRA warns WHO against one-size-fits-all nicotine pouch restrictions

Globenewswire -

CGTN: Head-of-state diplomacy anchors growing China-Russia partnership

CGTN: Head-of-state diplomacy anchors growing China-Russia partnership

Globenewswire -

Countdown Grant Explores How Cells Remove Damaged Mitochondria — Opening New Possibilities Across Parkinson’s, Chronic Disease, Rare Disease, and Aging

Countdown Grant Explores How Cells Remove Damaged Mitochondria — Opening New Possibilities Across Parkinson’s, Chronic Disease, Rare Disease, and Aging

Globenewswire -

Kanghong Pharmaceutical and Vanotech Announce Positive Phase 2b Results for KH607 in Major Depressive Disorder

Kanghong Pharmaceutical and Vanotech Announce Positive Phase 2b Results for KH607 in Major Depressive Disorder

Globenewswire -

Omantel Launches AI Centre of Excellence and AI Startups Program

Omantel Launches AI Centre of Excellence and AI Startups Program

Globenewswire -

Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock

Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock

Globenewswire -

XEM THÊM TIN MỚI